From: Intrauterine growth restriction alters kidney metabolism at the end of nephrogenesis
Compound | p value | q value | Identification | IUGR/control |
---|---|---|---|---|
P1 | 0.0001 | 0.0019 | Taurine | Down |
P2 | 0.0006 | 0.0238 | PE(18:3(6Z,9Z,12Z)/P-18:1(9Z)) | Down |
P3 | 0.0011 | 0.0248 | N-acetylglutamine | Up |
P4 | 0.0011 | 0.0248 | (2S)-2-hydroxy-2-(propan-2-yl)butanedioylcarnitine | Up |
P5 | 0.0011 | 0.0248 | PG(i-12:0/5-iso PGF2VI), PG(5-iso PGF2VI/i-12:0) | Up |
P6 | 0.0012 | 0.0248 | L-cysteine, D-cysteine | Down |
P7 | 0.0012 | 0.0248 | PC(15:0/18:2(9Z,12Z)) | Down |
P8 | 0.0014 | 0.0268 | PS(DiMe(13,5)/MonoMe(13,5)), PS(MonoMe(13,5)/DiMe(13,5)) | Up |
P9 | 0.0015 | 0.0268 | Cortisol, 18-hydroxycorticosterone, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione | Up |
P10 | 0.0024 | 0.0384 | PE(22:0/PGJ2), PE(PGJ2/22:0) | Up |